Insider trade

10% owner sold ~$4.5K of SPRB shares in the open market

Traded Oct 6, 2025 · Filed Oct 15, 2025

Why it stands out

A 10% owner of Spruce Biosciences sold $4.5K of Spruce Biosciences shares. The filing does not indicate a pre-arranged trading plan.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

10% ownerIndirect holding<$25K

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$4,484

Shares × reported transaction price

Timing vs results

53 days after results of Aug 14, 2025, 35 days before results of Nov 10, 2025

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Planned / mechanical clue

None found in footnotes

Only flagged when a footnote says so; never inferred

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $19.125 to $19.63. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The amount reported represents the Reporting Persons' pecuniary interest held through an investment in private funds. Each Reporting Person disclaims beneficial ownership in the securities reported on this Form 4 except to the extent of its or his pecuniary interest, if any, therein, and this report shall not be deemed to be an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.